funder-graph

FundersNYAIDS Vaccine Advocacy Coalition Inc › 2023

Grants paid by AIDS Vaccine Advocacy Coalition Inc, tax year 2023

EIN 94-3240841 · New York, NY · Form 990, Schedule I · NTEE P20

In tax year 2023, AIDS Vaccine Advocacy Coalition Inc (EIN 94-3240841) reported 7 grants paid totaling $1,116,117. Dataset version 2026.09.0, built 2026-09-03.

2020202220232024

Every grant, 2023

Grants reported by AIDS Vaccine Advocacy Coalition Inc for tax year 2023
Tax yearRecipientMatchAmountTypePurposeSource filing
2023International AIDS Vaccine Initiative New York, NYA$251,135paidHIV VACCINE AND BIOM202413109349301411
2023Internews Arcata, CAA$238,083paidHIV VACCINE AND BIOM202413109349301411
2023Family Health International 360 Durham, NCA$182,752paidHIV VACCINE AND BIOM202413109349301411
2023Health Global Access Project Inc Brooklyn, NYA$181,655paidTO INCREASE THE ACCO202413109349301411
2023Clinton Health Access Initiative Boston, MAA$134,777paidTO CREATE A PLATFORM202413109349301411
2023American Foundation for AIDS Research New York, NYA$73,615paidTO INCREASE ADOPTION202413109349301411
2023Mpact Global Action Los Angeles, CAA$54,100paidHIV VACCINE AND BIOM202413109349301411

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.